Palm Ulo 4
4 · Vaxxinity, Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Vaxxinity, Inc.VAXX
Palm Ulo
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2022-03-15+100,000→ 100,000 total→ Class A common stock (100,000 underlying)
Holdings
- 450(indirect: By Spouse)
Class A common stock
- 233,100
Stock Option (right to buy)
Exercise: $13.00Exp: 2031-11-11→ Class A common stock (233,100 underlying)
Footnotes (4)
- [F1]These securities are held by Kathrin Palm, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kathrin Palm in which the Reporting Person has no pecuniary interest.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A common stock.
- [F3]The Reporting Person received restricted stock units subject to a four-year vesting schedule, vesting 100% on March 15, 2026, subject to the Reporting Person's continued employment with the Issuer through the vesting date. The restricted stock units do not expire but are settled in shares of Class A common stock as soon as practicable after the vesting date.
- [F4]These options are subject to a four-year time-vesting schedule, with 25% vesting on November 11, 2022 and the remainder vesting in equal installments each month during the remainder of the vesting schedule, subject to the Reporting Person's continued employment with the Issuer through the vesting date.